Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tango Therapeutics, Inc. | President, Research & Development | Common Stock | 119K | $1.51M | $12.62 | Feb 7, 2024 | Direct |
C4 Therapeutics, Inc. | Chief Medical Officer | Common Stock | 20.1K | $131K | $6.52 | Jan 30, 2023 | Direct |
C4 Therapeutics, Inc. | Chief Medical Officer | Performance Restricted Stock Units | 18.8K | $119K | $6.36 | Jan 30, 2023 | Direct |
Tango Therapeutics, Inc. | President, Research & Development | Stock Option (Right to Buy) | 280K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Feb 6, 2024 | 2 | -$105K | 4 | Feb 8, 2024 | President, Research & Development |
TNGX | Tango Therapeutics, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | President, Research & Development |
TNGX | Tango Therapeutics, Inc. | Nov 1, 2023 | 1 | -$63K | 4 | Nov 2, 2023 | President, Research & Development |
TNGX | Tango Therapeutics, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 2, 2023 | President, Research & Development |
TNGX | Tango Therapeutics, Inc. | Feb 27, 2023 | 0 | $0 | 3 | Mar 2, 2023 | President, Research & Development Exhibit 24: Power of Attorney |
CCCC | C4 Therapeutics, Inc. | Jan 30, 2023 | 3 | -$10.1K | 4 | Feb 1, 2023 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | May 26, 2022 | 1 | -$7.73K | 4/A | Jun 14, 2022 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Feb 14, 2022 | 2 | $0 | 4 | Feb 16, 2022 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Jan 4, 2022 | 4 | -$378K | 4 | Jan 5, 2022 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Dec 22, 2021 | 2 | $32.5K | 4 | Dec 23, 2021 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Oct 8, 2021 | 2 | $64.9K | 4 | Oct 12, 2021 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Oct 1, 2021 | 5 | -$607K | 4 | Oct 5, 2021 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Jul 29, 2021 | 3 | -$600K | 4 | Aug 2, 2021 | Chief Medical Officer |
CCCC | C4 Therapeutics, Inc. | Jul 1, 2021 | 4 | -$472K | 4 | Jul 6, 2021 | Chief Medical Officer |